Susquehanna International Group
PRVB

Susquehanna International Group’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Susquehanna International Group’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-444,000
Closed -$10.7M – 13716
2023
Q1 		$10.7M Buy
444,000
+316,600
+249% +$3.97M ﹤0.01% 2352
2022
Q4 		$1.35M Buy
127,400
+35,600
+39% +$287K ﹤0.01% 5521
2022
Q3 		$413K Buy
91,800
+47,000
+105% +$214K ﹤0.01% 8982
2022
Q2 		$179K Sell
44,800
-30,900
-41% -$146K ﹤0.01% 10806
2022
Q1 		$554K Buy
75,700
+600
+0.8% +$3.59K ﹤0.01% 8718
2021
Q4 		$422K Sell
75,100
-26,300
-26% -$167K ﹤0.01% 9622
2021
Q3 		$649K Sell
101,400
-69,300
-41% -$445K ﹤0.01% 8717
2021
Q2 		$1.44M Buy
170,700
+57,100
+50% +$461K ﹤0.01% 6764
2021
Q1 		$1.19M Buy
113,600
+44,800
+65% +$630K ﹤0.01% 7255
2020
Q4 		$1.17M Hold
68,800
– – ﹤0.01% 6363
2020
Q3 		$883K Sell
68,800
-1,000
-1% -$12.6K ﹤0.01% 6422
2020
Q2 		$985K Buy
69,800
+19,100
+38% +$241K ﹤0.01% 5960
2020
Q1 		$466K Sell
50,700
-26,400
-34% -$340K ﹤0.01% 7098
2019
Q4 		$1.15M Buy
77,100
+27,800
+56% +$248K ﹤0.01% 5262
2019
Q3 		$336K Buy
+49,300
New +$499K ﹤0.01% 8055

Other funds holding PRVB

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Susquehanna International Group's PRVB Position: Q2 2023 in Review

Susquehanna International Group sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 363,758 shares — an estimated $8.77M sold.

Susquehanna International Group first reported a position in PRVB in Q2 2019 and held it in 16 quarters. The position peaked at $8.77M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

  • Susquehanna International Group reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 363,758 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $8.77M.
  • Susquehanna International Group first reported a position in Provention Bio, Inc. Common Stock in Q2 2019 and held it in 16 quarters.
  • Susquehanna International Group's Provention Bio, Inc. Common Stock position peaked at $8.77M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.